ATLANTA, GA – – (Globe Newswire – December 5, 2024) – – A shareholder class action lawsuit has been filed against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts about ASP Isotopes’s business, operations, and prospects, including allegations that: (1) ASP Isotopes overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; and (3) ASP Isotopes overstated the Company’s nuclear fuels operating segment results.

If you bought shares of ASP Isotopes between October 30, 2024 and November 26, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/asp-isotopes/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is February 3, 2025.